Legend

Presentation Icons

In Person

On Demand

Live Stream

All times listed are Eastern Standard Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.

Type here to filter the list

Saturday, Nov 16th
7:30 AM – 8:30 AM Eastern Time
MTP02A: Meet the Professor: Rheumatoid Arthritis - Interstitial Lung Disease
Location: Room 154A
Seminar Presenter: Paul Dellaripa, MD – Brigham and Womens Hospital
Rheumatoid arthritis (RA)
CME 1 hours
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
RA – Treatment Poster I
Rheumatoid arthritis (RA)
CME 0 hours
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
RA – Diagnosis, Manifestations, & Outcomes Poster I
Rheumatoid arthritis (RA)
CME 0 hours
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
Rheumatoid Arthritis – Etiology and Pathogenesis Poster
Rheumatoid arthritis (RA)
CME 0 hours
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0032: Increased Expression of Malondialdehyde-Acetaldehyde and Citrullinated Proteins in Myocardial Tissues During the Early Evolution of Collagen-Induced Arthritis
Abstract Poster Presenter: Wenxian Zhou, BS – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0033: Refined Autoantibody Profiles in RA Reveal That Primarily ACPAs Binding Non-glycine Citrulline Motifs Are Associated with Shared Epitope Alleles
Abstract Poster Presenter: Caroline Grönwall, PhD – Karolinska Institutet
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0034: Arthritogenic Subdoligranulum (S. Dido 7) Is Increased in Individuals At-Risk for and with Early RA and Decreases over Time During Development of Inflammatory Arthritis
Abstract Poster Presenter: Lyndsey Cole, MD (she/her/hers) – University of Colorado School of Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0035: Anti-CCP Generation in the Female Genital Tract Is Increased During the Postpartum Period in Women Without RA
Abstract Poster Presenter: Daniele Marcy, MD (she/her/hers) – University of Colorado
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0036: Deep Topic Modeling Deconvolves Cell States in Spatial Transcriptomic Profiles of Rheumatoid Arthritis Synovial Tissue
Abstract Poster Presenter: Preethi Periyakoil, PhD, BS (she/her/hers) – Weill Cornell Medical College
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0037: Clonal Haematopoiesis of Indeterminate Potential (CHIP) Is Associated with Disease Activity in Rheumatoid Arthritis
Abstract Poster Presenter: Mihir Wechalekar, MD,FRACP,PhD – Flinders Medical Centre and Flinders University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0038: The Role of Dual Specificity Phosphatase 22 (DUSP22) in Rheumatoid Arthritis: Mechanism and Genetic Investigations
Abstract Poster Presenter: Wei-Ting Hung, MD. PhD (she/her/hers) – Taichung Veteran General Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0039: Blockade of Soluble and Cell Surface PAD Activity Prevents the Generation of Citrullinated Autoantigens Recognized by RA Patients’ Serum
Abstract Poster Presenter: Gary Sims, PhD – AstraZeneca
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0040: Targeting Complement Factor B (CFB) via a Novel siRNA Therapy (AZD6912) to Treat Inflammatory Arthritis
Abstract Poster Presenter: Teneema Kuriakose, PhD, DVM – AstraZeneca Biopharmaceuticals
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0041: Disease Activity and Serological Inflammatory Markers Are Associated with TNF-a and IL-6-Induced Osteoclasts, but Not with RANKL-Induced Osteoclasts in Peripheral Blood Monocytes from Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Kazuhiro Yokota, MD, PhD – Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0042: Modulating Inflammation and Angiogenesis in an Advanced 3D Rheumatoid Arthritis Synovial Tissue Model
Abstract Poster Presenter: Sander Tas, MD, PhD – Amsterdam UMC
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0043: Inflammatory and Angiogenic Serum Profile of Refractory Rheumatoid Arthritis
Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0044: Synovial Phosphoproteomic Profiling in Early and Advanced Rheumatoid Arthritis (R4RA Trial) Identifies Specific Signaling Pathways Linked to Distinct Pathotypes
Abstract Poster Presenter: Myles Lewis, PhD,MRCP (he/him/his) – Queen Mary University of London
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0045: Proteomic Analysis of the Rheumatoid Arthritis Citrullinome Reveals an Enrichment of Citrullinated Complement Proteins
Abstract Poster Presenter: Liam O'Neil, MD, MHS – University of Manitoba
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0046: Impaired Neutrophil Extracellular Trap (NET) Degradation in Rheumatoid Arthritis (RA) and Pre-clinical RA Is Mediated by Anti-NET Antibodies
Abstract Poster Presenter: Jeba Atkia Maisha, BSc – University of Manitoba
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0047: Asthma Is Associated with Increased Serum IgA Antibodies to Citrullinated Peptide Antigenscompared to Healthy Controlsin Discovery and Validation Cohorts
Abstract Poster Presenter: Drayton Rorah, DO – University of Kansas, Internal Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0048: Role of the Chemokine CCL22 in Rheumatoid Arthritis Development
Abstract Poster Presenter: Maša Filipović, PhD – Karolinska Institutet
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0049: Inflammatory Priming by Anti-MAA Antibodies in Rheumatoid Arthritis
Abstract Poster Presenter: Marcelo Afonso, MSc – Karolinska Institutet
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0050: Elucidating Androgen Effects on Osteoclast Precursor Populations and Osteoclastogenesis
Abstract Poster Presenter: Kiana Chen, MS – University of Rochester School of Medicine and Dentistry
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0051: Impact of Tight Junction Proteins on Inflammatory Processes and Microbial Imbalance in Rheumatoid Arthritis
Abstract Poster Presenter: Arkaitz Mucientes, PhD – IBIMA Plataforma BIONAND
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0052: Single Cell RNA-sequencing Analysis Revealed Peripheral Blood and Synovial Alterations of Dendritic Cells in Rheumatoid Arthritis
Abstract Poster Presenter: Yuichi Suwa, MD (he/him/his) – University of Tokyo
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0053: Fasting Reduces an IL-17+/IFNg+ T Helper Cell-inducing Gut Pathobiont in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Martin Kriegel, MD, PhD – University of Münster
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0054: Supernatants from Macrophages Stimulated with Citrullinated and MAA-Modified Fibrinogen Contain PDGF-BB and TGF-b and Upregulate Fibrotic Markers in Human Lung Fibroblasts
Abstract Poster Presenter: Nozima Aripova, PhD – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0055: Activating STAT3 Mutations in CD8+ T Cells Correlate to Serological Positivity in Rheumatoid Arthritis
Abstract Poster Presenter: Donald Kimpel, MD – University of Virginia
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0056: Association of Soluble Immune Checkpoint Proteins with the Risk of Developing RA in ACPA-positive At-risk Individuals
Abstract Poster Presenter: Ryo Motoyama, MD – Tokyo Women’s Medical University School of Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0057: Flow Cytometry of Cells Within Induced Sputum from Individuals At-Risk for RA Reveals Relative Expansion of Small Macrophages
Abstract Poster Presenter: Hideto Takada, MD, PhD (he/him/his) – University of Colorado Anschutz Medical Campus
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0058: Bradykinin Receptor B1 Blockade Suppresses Soluble CD13-Induced Differentiation of Osteoclasts from Monocytes
Abstract Poster Presenter: Sei Muraoka, MD, PhD – Toho University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0059: Fragment Crystallizable (Fc)-Free Certolizumab Pegol Is Not Bound by Rheumatoid Factors, While Fc Containing Biological DMARDsAre, Driving ImmuneComplex Formation and Cellular Clearance
Abstract Poster Presenter: David Humphreys, PhD, BSc – UCB Pharma
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0060: Spectral Cytometry Shows Increased CD56hi NK Cells and New HLA-DR+CD56+ Phenotypes in RA
Abstract Poster Presenter: Estelle Khairallah, BA – SUNY Upstate Medical University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0061: Comparative Transcriptional Profiling of IPF and RA-ILD Lung Tissue Demonstrates Both Overlapping and Distinct Cell-specific Signaling Pathways
Abstract Poster Presenter: Joshua Sciurba, MD – University of Pittsburgh School of Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0062: Pro-Fibrotic Effects of Malondialdehyde-Acetaldehyde-Adducted and/or Citrullinated Proteins on Macrophages and Human Lung Fibroblasts
Abstract Poster Presenter: Lauren Klingemann, BS – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0063: Splicing into Action:Investigating the Role of Alternative Splicing in Rheumatoid Arthritis Neutrophils
Abstract Poster Presenter: Noga Rogel, MD – University of Washington
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0064: Anti-Citrullinated Protein Antibodies Arise During Affinity Maturation of Germline-Encoded Antibodies to Carbamylated Proteins in Rheumatoid Arthritis
Abstract Poster Presenter: Marta Escarra Senmarti, PhD – Johns Hopkins Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0065: Evidence of Membranolytic Targeting and Intracellular Citrullinationin Neutrophils Isolated from Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Fatemeh Moadab, MD – University of Washington
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0066: Association Between Gut Microbiota, Inflammation, and Epigenetics in Rheumatoid Arthritis Patients
Abstract Poster Presenter: José Manuel Lisbona-Montañez, PhD (he/him/his) – University of Málaga
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0456: Use of Machine Learning to Evaluate Incremental Value of Actigraphy Data for Classifying Treatment Response in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Jeffrey R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0457: Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis
Abstract Poster Presenter: Joshua F. Baker, MD, MS – University of Pennsylvania
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0458: Long-Term Outcomes in Seronegative Rheumatoid Arthritis
Abstract Poster Presenter: Elena Myasoedova, MD, PhD – Mayo Clinic
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0459: Tocilizumab Demonstrates Superior Inhibition of MMP-Mediated Basement Membrane Collagen Degradation Compared to Methotrexate or Placebo
Abstract Poster Presenter: Anne-Christine Bay-Jensen, PhD,MSc (she/her/hers) – Nordic Bioscience
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0460: Cartilage Damage or (sub)luxation of Finger Joints: Impact on Physical Function in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Takehisa Ogura, MD, PhD – Toho university
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0461: Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis
Abstract Poster Presenter: IVAN FERRAZ AMARO, MD – Hospital Universitario de Canarias
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0462: Circulating Mediators of Endothelial Dysfunction as Predictors of Incident Heart Failure in Rheumatoid Arthritis
Abstract Poster Presenter: Tate Johnson, MD – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0463: Evaluation of Inflammatory Indices as Predictive Biomarkers of Carotid Plaque in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Jose Antonio Davila Jimenez, MD (he/him/his) – Universidad Autónoma de Nuevo León
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0464: Increases in Paraoxonase-1 Activity over Time Associates with Reduced Risk of Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population
Abstract Poster Presenter: Amir Razmjou, MD, MSc (he/him/his) – UCLA / Veterans Affairs
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0465: Therapeutic Drug Monitoring of the Adalimumab Biosimilar (AMJEVITA™, Adalimumab-atto) Using Originator Adalimumab and Anti-Adalimumab Antibody Assays
Abstract Poster Presenter: Kelly Chun, PhD – Labcorp
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0466: Inpatient Outcomes of Rheumatoid Arthritis in Hospitalized Patients Using Cannabis: Data from the National Inpatient Sample
Abstract Poster Presenter: Karun Shrestha, MD – St. Barnabas Hospital Internal Medicine Residency
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0467: Lung Involvement in Early Rheumatoid Arthritis, Analysis of ERA UCLouvain Brussels FINDRA Cohort
Abstract Poster Presenter: Patrick Durez, n/a – Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0468: Plasma Calprotectin Assessed in Multiple Biological Treatment Strategies for Early Rheumatoid Arthritis over 48 Weeks
Abstract Poster Presenter: Hilde Berner Hammer, PhD (she/her/hers) – Diakonhjemmet Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0469: SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound
Abstract Poster Presenter: Jorge Juan Fragio Gil, MD,PhD (he/him/his) – Hospital General Universitario
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0470: New Approach for Early and Accurate Diagnosis of Rheumatoid Arthritis-related Interstitial Lung Disease: Matrix Metalloproteinases 7 and 9 as Novel Blood Biomarkers
Abstract Poster Presenter: Verónica Pulito Cueto, PhD – IDIVAL
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0471: Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Jose María Viotti Serra, MD – Hospital Universitario de Canarias
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0472: Impaired Cardiac Function in Contemporary Rheumatoid Arthritis Patients: A Comparative Pilot Study with Cardiovascular Magnetic Resonance-derived Strain Analysis
Abstract Poster Presenter: Michael T. Nurmohamed, MD, PhD – Amsterdam University Medical Centers & Reade Amsterdam
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0473: Immune Checkpoint–Induced Arthritis: A Comprehensive Single Cohort Descriptive Analysis from Clinical Evaluation to Histology
Abstract Poster Presenter: Francesco Natalucci, n/a – Sapienza University of Roma, Rheumatology, Department of Clinical, Internistic, Anesthesiological and cardiovascular sciences
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0474: Association Between Rheumatoid Arthritis and Survival After Cancer: A Systematic Literature Review and Meta-analysis
Abstract Poster Presenter: Joshua Hsieh, -None- – Lakeside
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0475: Rheumatoid Arthritis - Progressive Interstitial Lung Disease with Abatacept: Data from a Large National Multicenter Cohort
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0476: Baricitinib in Rheumatoid Arthritis - Interstitial Lung Disease. National Multicenter Study of 72 Patients
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0477: The Global Prevalence of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Abstract Poster Presenter: Hari Prasanna, MD (he/him/his) – University Of Western Australia
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0478: Skin Sodium in Patients with Rheumatoid Arthritis: Association with Blood Pressure and Disease Activity
Abstract Poster Presenter: Carolina Ramirez Becerra, MD – Vanderbilt University Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0479: Constructing and Using a Novel Nucleotide Transformer for Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Shant Ayanian, MD, MS – Mayo Clinic
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0480: Can't Sleep, Won't Sleep: A Systematic Review and Meta-Analysis of Insomnia Prevalence in 70,105 Rheumatoid Arthritis Patients
Abstract Poster Presenter: Mohamed Abdelsalam, MBBCH – Rheumatology, Rehabilitation and Physical medicine department - faculty of medicine -Misr University for science and technology
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0481: Differential Effect of Comorbidities on the Clinical Evolution of Early Arthritis by Sex
Abstract Poster Presenter: Marina Dueñas Ochoa, -None- (she/her/hers) – Hospital La Princesa
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0482: Endothelial Dysfunction and QRISK3 in Rheumatoid Arthritis
Abstract Poster Presenter: Ashit Syngle, Dr (he/him/his) – Healing Touch City Clinic
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0483: Obesity, Prednisone Use, and Patient-Reported Outcomes Are Predictors of Becoming Difficult-to-Treat in an RA Population Treated with a First-Line Biologic DMARD
Abstract Poster Presenter: Misti Paudel, PhD, MPH – Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0484: Cluster Analysis Based on Joint Characteristics: A Study of Joint Involvement Profiles in Early Rheumatoid Arthritis (ERA) Patients in China
Abstract Poster Presenter: Yafang Deng, MD – Peking Union Medical College Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0485: Biomarkers for Disease Activity and Response to Treatment in Early Rheumatoid Arthritis: Metabolomics and Machine Learning Analyses in NORD-STAR Cohort
Abstract Poster Presenter: Tahzeeb Fatima, PhD (she/her/hers) – University of Gothenburg
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0486: Associations Between Frailty and Incident Cancer and Cancer-related Mortality in Veterans with Rheumatoid Arthritis
Abstract Poster Presenter: Bhavik Bansal, MBBS – AIIMS, New Delhi
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0488: Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis
Abstract Poster Presenter: Pablo Martinez Calabuig, MD (he/him/his) – HOSPITAL GENERAL UNIVERSITARIO VALENCIA SPAIN
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0489: Use of Chair Sit-to-Stand as a Pragmatic Alternative to Assess Frailty in Rheumatoid Arthritis
Abstract Poster Presenter: Hannah Brubeck, BS (she/her/hers) – VA Puget Sound Health Care System
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0490: Improvements in Peri-fracture Care in Rheumatoid Arthritis (RA) Have Offset Increased Mortality
Abstract Poster Presenter: Owen Taylor-Williams, MD, BSc (he/him/his) – University of Western Australia
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0491: Small Molecule Metabolites, Potential Disease-specific Biomarkers for Predicting Treatment Response in Rheumatoid Arthritis
Abstract Poster Presenter: Jiayi Xu, BS – Sichuan University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0492: A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation
Abstract Poster Presenter: Douglas White, MD, PhD – Aspirus
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0493: An Algorithm Pipeline for Automated Metrical Analysis of Joint Swelling in Rheumatoid Arthritis via Smartphone Hand Photographs
Abstract Poster Presenter: Cinja Koller, MSc, BA – Doctoral School, Faculty of Biology and Medicine, University of Lausanne
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0494: Usefulness of the Neutrophil-to-Lymphocyte Ratio, the Platelet-to-Lymphocyte Ratio and the Systemic Immune Inflammatory Index in Assessing Disease Activity in Rheumatoid Arthritis Patients
Abstract Poster Presenter: Yelitza Cecilia Velarde Mejía, MD – Hncase
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0495: Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients
Abstract Poster Presenter: Yelitza Cecilia Velarde Mejía, MD – Hncase
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0496: Dissecting Early RA Patient Trajectories Through Time-independent Disease State Identification Identifies Distinct Patterns Dissected by Inflammation in Blood or Joints
Abstract Poster Presenter: Rachel Knevel, MD, PhD – LUMC
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0497: Relationship Between the Complement System and Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Adrián Quevedo-Rodríguez, DM – Servicio Canario de Salud
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0498: ACPA Subtypes, RF Isotypes, and the Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Poster Presenter: Jacob Welch, MD – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0499: PD-1hiCXCR5-CD4+T Peripheral Helper Cells Enrich in Rheumatoid Arthritis and Predict Clinical Response to Anti-TNF Treatment
Abstract Poster Presenter: Wanki Ho, MMSc (she/her/hers) – Peking University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0500: An Update on the Integrated Safety Analysis of Filgotinib in Patients with Moderate to Severe Active Rheumatoid Arthritis over a Median of 4.3 Years
Abstract Poster Presenter: Kevin Winthrop, MD, MPH – Oregon Health & Science University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0501: How Fast Do JAK-inhibitors, TNF-inhibitors, Abatacept and IL-6 Inhibitors Act in Rheumatoid Arthritis? An International Collaboration of Registers of Rheumatoid Arthritis Patients (the "JAK-pot" Study)
Abstract Poster Presenter: Kim Lauper, MD, PhD – Geneva University Hospitals
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0502: Similar Efficacy, PK, Safety, and Immunogenicity of Tocilizumab Biosimilar (CT-P47) and Reference Tocilizumab in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Week 52 Results from the Phase III Single Transition Study
Abstract Poster Presenter: Gerd Burmester, MD – Charité - Universitätsmedizin Berlin
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0503: Use of Janus Kinase Inhibitors Before and After European Medicines Agency Safety Recommendations
Abstract Poster Presenter: Stefan Kleinert, MD – Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN)
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0504: Janus Kinase Inhibitors Persist Longer Than Biologics in Rheumatoid Arthritis: Retrospective Analysis of Real-world Outpatient Data from the German Rhadar Database
Abstract Poster Presenter: Stefan Kleinert, MD – Praxisgemeinschaft Rheumatologie - Nephrologie (PGRN)
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0505: UseofaMolecularSignatureResponseClassifiertoPredictInadequateResponsetoTNFiResultsinFewer Patients Prescribed TNFi
Abstract Poster Presenter: George Karpouzas, MD – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0506: 24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis: The 2024 Interim Report
Abstract Poster Presenter: Takao Fujii, MD, PhD – Wakayama Medical University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0507: Neutrophil Activation Markers Can Predict Rheumatoid Arthritis Treatment Response to the Janus Kinase 1/2 Inhibitor Baricitinib
Abstract Poster Presenter: Christian Lood, PhD – University of Washington
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0508: Real-World Evidence for GP2015 in Patients with Rheumatoid Arthritis: Safety Outcomes from German Observational Data
Abstract Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0509: Trends in Initiation of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among Commercially-Insured US Adults, 2001-2021
Abstract Poster Presenter: Jeffrey Sparks, MD,MSc – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0510: Applying Machine Learning Tools for Personalized Healthcare: Predicting Responses to Biologics in Rheumatoid Patients Through Comorbidity and Blood Test Analysis
Abstract Poster Presenter: Yaser Ali, MD – Mubarek Al Kabeer Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0511: Do High Rheumatoid Factor Levels Impact Response to Certolizumab Pegol in Patients with Inadequately Controlled Rheumatoid Arthritis? A Post Hoc Analysis of a Phase 3b Trial
Abstract Poster Presenter: Josef Smolen, MD – Medical University of Vienna
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0512: Co-stimulatory Blockade Causes Targeted Quantitative and Clonotypic Contractions in Extrafollicular B-cell Subsets in Seropositive RA Patients
Abstract Poster Presenter: Jasmine Shwetar, -None- – New York School of Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0513: Effects of Cumulative Rituximab Exposure in Patients with Rheumatoid Arthritis: Results from Cohort at a Tertiary Academic Health Care Setting
Abstract Poster Presenter: Ioasaf Karafotias, PhD (he/him/his) – King's College London
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0514: Efficacy, Safety and Mechanism of Butyrate in the Treatment of Rheumatoid Arthritis (RA)
Abstract Poster Presenter: Jing He, MD – Rheumatology
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0515: Scavenging Isolevuglandins with 2-HOBA Decreases In Vitro Neutrophil Extracellular Traps in Cells from Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Olivia Posey, BS – Vanderbilt University Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0516: Management of Elederly Patients with Rheumatoid Arthritis Treated with Tocilizumab : Comparison of Patients over and Under 75 Years Old
Abstract Poster Presenter: Bruno Fautrel, MD,PhD – Sorbonne University - APHP
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0517: Characterizing Infusion-Related Reactions in Patients with Rheumatoid Arthritis Treated with Biologic DMARDs: Observations from the KOBIO Registry
Abstract Poster Presenter: Ji-Won Kim, MD – Ajou university school of medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0518: Sustained Patient Meaningful Outcomes of Pain and Fatigue Relief and Improved Physical Functioning with Filgotinib in Rheumatoid Arthritis: A Post Hoc Analysis
Abstract Poster Presenter: Rieke Alten, MD – SCHLOSSPARK KLINIK, University Medicine Berlin
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0519: Comparable Malignancy Risk of Janus Kinase Inhibitors with Conventional Synthetic and Biologic DMARDs in Asian Patients with Rheumatoid Arthritis: A Comprehensive Analysis from Two Medical Centers
Abstract Poster Presenter: Ming-Han Chen, PhD – Division of Allergy, Immunology & Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0520: Disease Duration Differentially Affects the Clinical Efficacy of Biologics and JAK Inhibitors in Rheumatoid Arthritis: The ANSWER Cohort Study
Abstract Poster Presenter: Yoichi Nakayama, MD – Kyoto University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0521: Transcriptome Analysis of Drug Response in a Large Cohort of Immune-Mediated Inflammatory Disease Patients Supports Advanced Combination Therapy in Rheumatoid Arthritis
Abstract Poster Presenter: Ernest Choy, MD – Cardiff University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0522: Hematological Impact Assessment of Tofacitinib, Baricitinib, and Upadacitinib in Rheumatoid Arthritis Treatment
Abstract Poster Presenter: Chang Keun Lee, M.D., Ph.D. – Asan Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0523: Distinct Peripheral Blood Immune Cell Sub-population Signatures at Baseline of Tofacitinib or Adalimumab Initiation Are Associated to Clinical Responses at 6 Months
Abstract Poster Presenter: Prodromos Sidiropoulos, MD – University of Crete, Laboratory of Rheumatology, Autoimmunity and Inflammation. University Hospital, Rheumatology, Clinical Immunology. Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Greece
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0524: Evaluating Dose Reduction of Biologic Treatments in Rheumatoid Arthritis: Predicting Flares Using Clinical and Molecular Biomarkers
Abstract Poster Presenter: Laura Galindo Domínguez, MD – Instituto de Investigación Biomédica de A Coruña (INIBIC)
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0525: Assess the Effect of Increasing the Dose of Folic Acid Supplementation in Patients of Rheumatoid Arthritis with Methotrexate Intolerance - A Randomised Controlled Trial
Abstract Poster Presenter: Harshith Sai Koneti, MD (he/him/his) – PGIMER, Chandigarh
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0526: Comparing Immunogenicity and Safety Following Transition from Reference Rituximab to Biosimilar Rituximab (DRL_RI) in Patients with Rheumatoid Arthritis: A Randomized, Double-blind, Phase 3 Study
Abstract Poster Presenter: Narendra Maharaj, MD – Dr Reddys Laboratories Ltd
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0527: Risk Factors for Leukopenia in Asian Patients with Rheumatoid Arthritis Undergoing Tocilizumab
Abstract Poster Presenter: Ping Hsuan Kuo, MD – Taipei Veteran General Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0528: Consequences of Switching Originator Biological Therapies to Its Biosimilars in Patients with Immune-mediated Diseases in a Mexican Cohort
Abstract Poster Presenter: Mariana Castañeda-Martínez, MD – ISSSTE
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0529: Discontinuation of Targeted Disease-Modifying Antirheumatic Agents in Older Patients with Rheumatoid Arthritis: Retrospective Analysis of Medicare Data
Abstract Poster Presenter: Yinan Huang, PhD, MS – Department of Pharmacy Administration, University of Mississippi School of Pharmacy
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0530: Long-term Effectiveness of a Lifestyle Intervention for Rheumatoid Arthritis: Two-year Follow-up After the “Plants for Joints” Randomized Clinical Trial
Abstract Poster Presenter: Carlijn Wagenaar, MD – Reade Rheumatology Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0531: Costs and Clinical Outcomes of the Rheumatoid Arthritis Medication Tapering Cohort
Abstract Poster Presenter: Tarun Sharma, MD – Allegheny Health Network
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0532: An Immune-molecular Signature Specifically Modulated by JAK Inhibitors Ex Vivo May Serve as a Predictor of Therapy Response In Vivo to These Drugs
Abstract Poster Presenter: Chary Lopez-Pedrera, PhD (she/her/hers) – IMIBIC - Reina Sofia Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0533: Using Adalimumab Serum Concentration to Choose a Subsequent DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment (ADDORA-switch): Results of a Blinded Randomized Test Treatment Trial
Abstract Poster Presenter: Maike Wientjes, MSc – Sint Maartenskliniek
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0534: Patient Reported Outcomes and Disease Activity from a Phase 1 Double-Blind Randomized Clinical Trial of Allogeneic Mesenchymal Stem Cells in Early Rheumatoid Arthritis
Abstract Poster Presenter: Alexandre Matar, MD – MetroHealth
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0535: Oral Glucocorticoid Premedication Is at Least as Effective as Intravenous Glucocorticoid Premedication for Prevention of Infusion-related Reactions to Rituximab in Rheumatoid Arthritis Patients
Abstract Poster Presenter: Pauline Bovens, MSc (she/her/hers) – Sint Maartenskliniek
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0536: A Population Modeling and Simulation of the Effect of Obexelimab Exposure on the QTc Interval in Healthy Volunteers and Patients with Rheumatoid Arthritis or IgG4-Related Disease
Abstract Poster Presenter: Claire Mukashyaka, MS – Zenas BioPharma
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0537: Evaluating the Usage of Janus Kinase Inhibitors in Rheumatology and Its Impact on Cardiovascular Risk
Abstract Poster Presenter: Knkush Hakobyan, MD (she/her/hers) – Capital Health Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
10:30 AM – 12:30 PM Eastern Time
0538: Factors Associated with Upadacitinib Persistence and Risk Minimization Measures in Patients with Rheumatic Diseases in a Real-world Setting. UPAreal Study
Abstract Poster Presenter: Maria Vanesa Hernandez Hernandez, MD – Hospital Universitario de Canarias
Rheumatoid arthritis (RA)
Saturday, Nov 16th
11:30 AM – 12:30 PM Eastern Time
MTP02B: Meet the Professor: Rheumatoid Arthritis - Interstitial Lung Disease
Location: Room 154A
Seminar Presenter: Paul Dellaripa, MD – Brigham and Womens Hospital
Rheumatoid arthritis (RA)
CME 1 hours
Saturday, Nov 16th
1:00 PM – 2:30 PM Eastern Time
16S52: Abstracts: RA – Diagnosis, Manifestations, & Outcomes I: Breathe: RA-ILD
Location: Room 146AB
Abstract Moderator: Kristen Demoruelle, MD,PhD – University of Colorado Anschutz Medical Campus
Abstract Moderator: Bindee Kuriya, MD,MS (she/her/hers) – University of Toronto - Toronto
Rheumatoid arthritis (RA)
CME 0 hours
Saturday, Nov 16th
1:00 PM – 1:15 PM Eastern Time
0799: Peripheral Biomarker Signatures and a Genetic Risk Score Improve the Identification of RA-ILD Beyond Clinical Risk Factors
Location: Room 146AB
Presenting Author: Austin Wheeler, MD – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
1:15 PM – 1:30 PM Eastern Time
0800: Associations of Rheumatoid Arthritis Polygenic Risk with Age at Onset, Serostatus, and Interstitial Lung Disease
Location: Room 146AB
Presenting Author: Gregory McDermott, MD, MPH – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
1:30 PM – 1:45 PM Eastern Time
0801: Neutrophil Activation as a Novel Marker of Lung Disease in Rheumatoid Arthritis
Location: Room 146AB
Presenting Author: Jia Shi, MD – University of Washington
Rheumatoid arthritis (RA)
Saturday, Nov 16th
1:45 PM – 2:00 PM Eastern Time
0802: Disease Activity Is Strongly Associated with RA-related Lung Disease and Interstitial Lung Disease in Early RA: Results from a Multicenter, Prospective Cohort Study
Location: Room 146AB
Presenting Author: Gregory McDermott, MD, MPH – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Saturday, Nov 16th
2:00 PM – 2:15 PM Eastern Time
0803: Serum Adipokines and Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort
Location: Room 146AB
Presenting Author: Anna Haggart, MD – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
2:15 PM – 2:30 PM Eastern Time
0804: Serologic and Clinical Predictors of Progressive Pulmonary Fibrosis in Rheumatoid Arthritis-associated Interstitial Lung Disease Progression: A Prospective Longitudinal Cohort
Location: Room 146AB
Presenting Author: Sung Hae Chang, MD, PhD, MPH – Brigham and Women's Hospital /Harvard Medical School /Soonchunhyang University College of Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
3:00 PM – 4:30 PM Eastern Time
16S65: Abstracts: RA – Diagnosis, Manifestations, & Outcomes II: Bad Blood (Serologic and Imaging Biomarkers)
Location: Ballroom B
Abstract Moderator: Bindee Kuriya, MD,MS (she/her/hers) – University of Toronto - Toronto
Abstract Moderator: Liam O'Neil, MD, MHS – University of Manitoba
Rheumatoid arthritis (RA)
CME 0 hours
Saturday, Nov 16th
3:00 PM – 3:15 PM Eastern Time
0867: Development of a Remote Patient Monitoring System Based on a Novel Digital Biomarker for Swelling in Rheumatoid Arthritis
Location: Ballroom B
Presenting Author: Marc BLANCHARD, MSc – CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Rheumatoid arthritis (RA)
Saturday, Nov 16th
3:15 PM – 3:30 PM Eastern Time
0868: Autoantibodies to Joint-related Proteins Predict Severe Joint Destruction in Difficult-to-treat Rheumatoid Arthritis Patients
Location: Ballroom B
Presenting Author: Inger Gjertsson, MD, PhD – Institutionen för medicin, avd för reumatologi och inflammationsforskning
Rheumatoid arthritis (RA)
Saturday, Nov 16th
3:30 PM – 3:45 PM Eastern Time
0869: Deciphering Pathogenic Phenotypes by Multi-modal Deep Single-cell Blood Immunophenotyping in Individuals At-risk for Rheumatoid Arthritis
Location: Ballroom B
Presenting Author: Jun Inamo, MD, PhD – University of Colorado School of Medicine
Rheumatoid arthritis (RA)
Saturday, Nov 16th
3:45 PM – 4:00 PM Eastern Time
0870: The Impact of Body Mass Index on Cardiovascular Risk in Rheumatoid Arthritis Varies Across Anticitrullinated Protein Antibody Status and Biologic Use
Location: Ballroom B
Presenting Author: George Karpouzas, MD – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
Saturday, Nov 16th
4:00 PM – 4:15 PM Eastern Time
0871: Disease-associated Central Nervous System Activation Predicts Good Clinical Response to Tumor Necrosis Factor Inhibition in Rheumatoid Arthritis Patients - "The PreCePRA Study"
Location: Ballroom B
Presenting Author: Dr. Hans Jürgen Rech, MD – Universitätsklinik Erlangen, Medizinische Klinik 3
Rheumatoid arthritis (RA)
Saturday, Nov 16th
4:15 PM – 4:30 PM Eastern Time
0872: Investigating the Natural Improvement of Rheumatoid Arthritis During Pregnancy
Location: Ballroom B
Presenting Author: Damini Jawaheer, PhD, MS – Northwestern University
Rheumatoid arthritis (RA)
Saturday, Nov 16th
4:30 PM – 5:30 PM Eastern Time
MTP08A: Meet the Professor: Rheumatoid Arthritis
Location: Room 154B
Seminar Presenter: Iain McInnes, MD – University of Glasgow, College of Medical Veterinary and Life Sciences
Rheumatoid arthritis (RA)
CME 1 hours
Sunday, Nov 17th
7:30 AM – 8:30 AM Eastern Time
MTP08B: Meet the Professor: Rheumatoid Arthritis
Location: Room 154B
Seminar Presenter: Iain McInnes, MD – University of Glasgow, College of Medical Veterinary and Life Sciences
Rheumatoid arthritis (RA)
CME 1 hours
Sunday, Nov 17th
10:00 AM – 11:30 AM Eastern Time
17S14: Rheumatoid Arthritis-Associated Interstitial Lung Disease: Advances in Screening, Diagnosis and Patient Phenotyping
Location: Room 144ABC
Moderator: Samuel Good, MD – University of California, Los Angeles
Rheumatoid arthritis (RA)
CME 1.5 hours
Sunday, Nov 17th
10:00 AM – 10:30 AM Eastern Time
Molecular Phenotypes of RA-ILD: An In-Depth Analysis of Bronchoalveolar Lavage Biomarkers
Location: Room 144ABC
Speaker: Scott Matson, MD – University of Kansas
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 11:00 AM Eastern Time
Identification of ILD in RA: The Use of Text Mining of HRCT Scans
Location: Room 144ABC
Speaker: Bryant England, MD, PhD – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
11:00 AM – 11:30 AM Eastern Time
Can Nailfold Capillaroscopy Improve Our Ability to Identify in Patients with ILD, Associated Underlying Rheumatic Diseases
Location: Room 144ABC
Speaker: Vanessa Smith, PhD, MD – Ghent University Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
RA – Animal Models Poster
Rheumatoid arthritis (RA)
CME 0 hours
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
RA – Treatment Poster II
Rheumatoid arthritis (RA)
CME 0 hours
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
RA – Diagnosis, Manifestations, & Outcomes Poster II
Rheumatoid arthritis (RA)
CME 0 hours
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0935: Molecular Degraders of Extracellular Protein (MoDEsTM) Rapidly and Effectively Remove Interstitial IgG and Disease-Relevant Immune Complexes Through Endo-lysosomal Degradation in the Liver
Abstract Poster Presenter: Charlotte Spliid, PhD – Biohaven Pharmaceuticals
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0936: Schnurri-3 Inhibition Protects from NF-kB-induced Bone Loss in Inflammatory Arthritis
Abstract Poster Presenter: Priyanka Kushwaha, PhD (she/her/hers) – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0937: A Novel Quantitative Method Reveals Bone-Structural Changes During Course of Inflammatory Arthritis
Abstract Poster Presenter: Anders Nguyen, MSc – University of Gothenburg
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0938: Group 2 Innate Lymphoid Cells Promote T Cell Activation and Development of Autoimmune Arthritis
Abstract Poster Presenter: Agnieszka Lastowska, MSc – University of Gothenburg
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0939: A Joint-targeting Peptide Enhances the Therapeutic Efficacy of Liposomal Drug Delivery in Experimental Rheumatoid Arthritis
Abstract Poster Presenter: Hemalatha Nanjaiah, PhD (she/her/hers) – School of medicine
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0940: Trans-endothelial Migration of Synovial Fibroblasts Promotes Arthritis Severity Through a PKD1-mediated Feedback Loop
Abstract Poster Presenter: Jaeyeon Kim, PhD – Cedars-Sinai Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0941: DC-9476, a Novel Selective BRD4(BD2) Inhibitor, Improves Arthritis Scores in Preclinical Models of Rheumatoid Arthritis by Regulating Key Inflammatory Pathways
Abstract Poster Presenter: Kulveer Mankia, MD – University of Leeds
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0942: An Aged K/BxA Arthritis Mouse Model Develops Features of Interstitial Lung Disease with Pulmonary Fibrosis and Bronchus-Associated T-Cell Aggregates Without a Pulmonary Insult, and Correlates with Worsening Arthritis Scores
Abstract Poster Presenter: Amir Razmjou, MD, MSc (he/him/his) – UCLA / Veterans Affairs
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0943: Cytosporone B, a Selective Agonist of Nr4a1, Inhibits Th17 Differentiation and Alleviates Experimental Arthritis in SKG Mice
Abstract Poster Presenter: Yoichi Nakayama, MD – Kyoto University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0944: Targeting Defective Macrophages to Restore Resolution of Inflammation in Rheumatoid Arthritis -Perspectives for an Autologous Secretome Therapy
Abstract Poster Presenter: ERIC TOUSSIROT, MD,PhD (he/him/his) – university hospital of BESANCON
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0945: Involvement of Cellular Senescence in Rheumatoid Arthritis-associated Interstitial Lung Disease of SKG Mice
Abstract Poster Presenter: Eri Watanabe, MD,PhD – Toho University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0946: Tissue Resident Monocyte-lineage Cells (TR-MC) Exist as Two Different Subpopulations
Abstract Poster Presenter: Yidan Wang, MS – Northwestern University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0947: REX-7117 Is a Highly Potent and Selective Oral STAT3 Inhibitor That Demonstrated Potential Efficacy and Safety Differentiation versus JAK/TYK2 Targeting in Preclinical Models of Inflammatory Arthritis
Abstract Poster Presenter: Paul Smith, PhD (he/him/his) – Recludix Pharma
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0948: Neuronal Intestinal Dysplasia Due to Ncx Gene Deficiency Attenuates the Severity of Experimental Arthritis in Mice
Abstract Poster Presenter: Takayoshi Owada, MD, PhD – Dokkyo Medical University Saitama Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0949: CCN1 Is a Novel Therapeutic Target for Reducing Structural Damage in Rheumatoid Arthritis: Demonstration from 2 Preclinical Models
Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
0950: Immunization of Arthritis Prone Mice with Malondialdehyde-Acetaldehyde (MAA) Modified Vimentin Induces Fibrotic Lung Changes
Abstract Poster Presenter: Wenxian Zhou, BS – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1324: Rheumatoid Arthritis Associated Interstitial Lung Disease - Patient Perceptions and Recommendations
Abstract Poster Presenter: Shirish Dubey, MBBS, FRCP, MMed (he/him/his) – Oxford University Hospitals NHS FT
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1325: The Association Between the Number of Teeth and All-Cause as Well as Cardiovascular Mortality Among Patients with RA: NHANES from 1999 to 2004
Abstract Poster Presenter: Jiaqian Zhang, -None- – Sichuan University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1326: Which Biomarkers Indicate Imminent Progression to Inflammatory Arthritis in High Risk CCP Positive Persons?
Abstract Poster Presenter: Laurence Duquenne, MD – Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, United Kingdom
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1327: Association of Rheumatoid Arthritis and Frailty Status with Mortality in Patients with Renal Cell Carcinoma
Abstract Poster Presenter: Sherwin Novin, MD – University of Washington
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1328: Carpal Tunnel Syndrome Is an Early Unrecognized Feature of Rheumatoid Arthritis: A Population-Based Study
Abstract Poster Presenter: Roslin Jose George, MBBS, MPH – Mayo Clinic
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1329: Investigating Predictors of Transfusion in Rheumatoid Arthritis and Osteoarthritis Patients Undergoing Knee Arthroplasty
Abstract Poster Presenter: Stephen Batter, BA – Cornell University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1330: Increased Levels of F-calprotectin in Patients with Early Rheumatoid Arthritis at Diagnosis
Abstract Poster Presenter: Johan Karlsson Wallman, MD, PhD – Lund University and Skane University Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1331: Does Refractory Rheumatoid Arthritis Status Matter in Modeling Patient Global Assessment Trajectories over 20 Years in a Large US Registry?
Abstract Poster Presenter: Sofia Pedro, MS (she/her/hers) – Forward, The National Databank for Rheumatic Diseases
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1332: Financial Distress and Its Determinants in Adults with Rheumatoid Arthritis
Abstract Poster Presenter: Amber Brown Keebler, MD (she/her/hers) – University of Nebraska Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1333: Deciphering Variation in Real-World Early RA Outcomes: A Longitudinal Analysis of the Canadian Early Arthritis Cohort (CATCH) Study
Abstract Poster Presenter: Susan Bartlett, PhD (she/her/hers) – Centre for Outcomes Research & Eval
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1334: Assessing the Performance of Validated Frailty Instruments in Veterans with Rheumatoid Arthritis (RA)
Abstract Poster Presenter: Kylie Riggles, BS (she/her/hers) – Puget Sound Veteran's Affairs Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1335: The Association of Patient-Reported Non-Articular Pain with Musculoskeletal Pain Diagnoses and RA Disease Activity in a Prospective Real-World Cohort of Patients with Early RA
Abstract Poster Presenter: Charis Meng, MD – Hospital for Special Surgery
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1336: Risk of Malignancy Under the Treatments with Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: An Analysis Using Japanese Health Insurance Database
Abstract Poster Presenter: Ryoko Sakai, MSc, MPH, DrPH – Meiji Pharmaceutical University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1337: Gender and Ethnic Differences (or Lack Thereof) in Perceived Disease Burden in RA
Abstract Poster Presenter: Rupak Thapa, MD – Assistant Professor
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1338: Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study
Abstract Poster Presenter: Mohammad Movahedi, MD, PhD (he/him/his) – Toronto General Hospital Research Institute, University Health Network
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1339: When Medications Fail: A Mixed Methods Study Evaluating the Experience and Health-Related Quality of Life (HRQOL) of Adults with Rheumatoid Arthritis Non-Responsive to Treatment
Abstract Poster Presenter: Karen Schifferdecker, PhD, MPH – Geisel School of Medicine at Dartmouth
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1340: Characteristics and Long-term Outcomes of Patients with Rheumatoid Arthritis and Concurrent Calcium Pyrophosphate Deposition Disease
Abstract Poster Presenter: Natalie Schanzer, BA – Perelman School of Medicine
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1341: Evaluation of Width Range Index (WRI) and Neutrophil-to-Lymphocyte Ratio (NLR) in Assessing Disease Activity in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Santiago Dans Caballero, -None- – H. U. Reina Sofía
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1342: Utility of Anti-Carbamylated Antibodies in Early Rheumatoid Arthritis in South Asian Population
Abstract Poster Presenter: CHANDHU S, DM – CMC Vellore
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1343: Heightened Gout Risk in Patients with Rheumatoid Arthritis: A National Cohort Study
Abstract Poster Presenter: Jaejoon Lee, MD;PhD – Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1344: Forced Vital Capacity Trajectories and Risk of Lung Transplant and ILD-Related Mortality Among Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease
Abstract Poster Presenter: Rathnam Venkat, BS – Tufts University School of Medicine
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1345: Long-term Changes in Coronary Calcium Score Levels Among Patients with Rheumatoid Arthritis: A Cohort Study
Abstract Poster Presenter: Cristina Corrales, MD – Rheumatology, Marques de Valdecilla University Hospital. IDIVAL
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1346: Early Diagnosis of Rheumatoid Arthritis: Role of Joint Ultrasound Assessment
Abstract Poster Presenter: Cristina Corrales, MD – Rheumatology, Marques de Valdecilla University Hospital. IDIVAL
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1347: Interest of DAS28-γGT in Assessing Cardiovascular Risk Activity in Rheumatoid Arthritis in Routine Practice
Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1348: Analysis of Body Composition in Patients with Moderate-Severe Rheumatoid Arthritis Treated with Anti-TNF Drugs
Abstract Poster Presenter: Aimara Garcia Studer, MD – Hospital Regional Universitario de Malaga
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1349: Two Composite Cytokine Scores Predict Flare and Drug-free Remission in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: John Isaacs, PhD;MBBS – Translational and Clinical Research Institute, NIHR Newcastle Biomedical Research Centre, Newcastle University and The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1350: Relationship Between Salivary and Stool Microbiome with Disease Activity and Vascular Function in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Tulsi Joishy, PhD – vanderbilt university medical center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1351: Development of Noninvasive Assessment Technology for Rheumatoid Arthritis Based on Contact Property Measurements
Abstract Poster Presenter: Woo-Joong KIM, MD, PhD – Chung-Ang University Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1352: The Associations Between Genetic Factors and Rheumatoid Arthritis Treatment Patterns: Data from Two Large Healthcare Systems
Abstract Poster Presenter: Gregory McDermott, MD, MPH – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1353: Association Between Frailty and Incident Cancer in Newly Diagnosed Rheumatoid Arthritis
Abstract Poster Presenter: Bhavik Bansal, MBBS – AIIMS, New Delhi
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1354: The Association of Genetic Variation in PTPN22 and Rheumatoid Arthritis Disease Activity
Abstract Poster Presenter: Thomas Riley, IV, MD – University of Pennsylvania
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1355: Genetically-determined Variation in C-reactive Protein Impacts Disease Activity Assessment in Rheumatoid Arthritis
Abstract Poster Presenter: Thomas Riley, IV, MD – University of Pennsylvania
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1356: Association Between Vascular Inflammation and Kidney Function in Patients with Rheumatoid Arthritis: Secondary Analysis of TARGET Trial
Abstract Poster Presenter: Sho Fukui, MD, MPH – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1357: Kidney Function in Rheumatoid Arthritis: Estimating Glomerular Filtration Rate Using Creatinine versus Cystatin C in a Secondary Analysis of the TARGET Trial
Abstract Poster Presenter: Sho Fukui, MD, MPH – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1358: A Step Towards Personalised Medicine - Development and Efficacy of Machine Learning Based Smart-Web Application for Prediction of Steroid Induced Hyperglycemia in Patients with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases
Abstract Poster Presenter: Prudhvi Krishna Manyam, MD – Amrita Institute of Medical Sciences
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1359: Association of Coronary Artery Calcium Score and Growth Differentiation Factor 15 in Rheumatoid Arthritis
Abstract Poster Presenter: Jessica Roldan Ortega, MD – INSTITUTO NACIONAL DE CARDIOLOGIA
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1360: Impact of Maintaining Low Disease Activity on Patient Outcomes and Healthcare Resource Utilization in Rheumatoid Arthritis Patients Receiving Advanced Treatment
Abstract Poster Presenter: Nancy Shadick, MD, MPH – Brigham & Women's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1361: The Effect of Disease Activity on Cardiovascular Risk Varies According to Rheumatoid Factor and Anticitrullinated Protein Antibody Status in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: George Karpouzas, MD – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1362: Comparative Effectiveness of Upadacitinib versus Other JAK Inhibitors in Patients with Rheumatoid Arthritis in a Global Real-World Setting
Abstract Poster Presenter: Roberto Caporali – University of Milan, Department of Rheumatology, ASST Gaetano Pini-CTO
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1363: Prevalence and Predictors of Orthopaedic Surgery in Rheumatoid Arthritis After 12-Years’ Follow-Up (ESPOIR Cohort)
Abstract Poster Presenter: Baptiste Quere, MD – Centre Hospitalier Regional Universitaire (CHU) de Brest
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1364: Machine Learning-Driven Models for Disease Activity Prediction and Therapeutic Response Evaluation in Rheumatoid Arthritis Patients: An Analysis of Data from the Multicentre, Prospective, Egyptian Collage of Rheumatology (ECR) Study Group
Abstract Poster Presenter: Nevin Hammam, MD, PhD (she/her/hers) – Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1365: Clinical Conditions Associated with Genetic Predisposition to Rheumatoid Arthritis in Real-World Settings
Abstract Poster Presenter: Vivian Kawai, MD – Vanderbilt University Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1366: Methotrexate Maintenance in Rheumatoid Arthritis, Two Years After Initiation of a First Targeted Therapy: Results from the Prospective STRATEGE2 Study
Abstract Poster Presenter: Cécile Gaujoux-Viala, PhD (she/her/hers) – CHU Nîmes
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1367: Maintained Improvement of Disease Activity and Patient-reported Outcomes (PROs) with Filgotinib in Patients with Rheumatoid Arthritis (RA) in the Real World: Up to 2-year Interim Data from FILOSOPHY
Abstract Poster Presenter: James Galloway, MBBS – King's College London
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1368: Do CsDMARDs Still Play a Significant Role in Managing Rheumatoid Arthritis in the Current Biologic/JAKI Era? A Prospective Observational Study to Estimate the Extent of Response to Conventional Synthetic DMARDs in RA– Experience from a Tertiary Care Center in South India
Abstract Poster Presenter: Prabhu Vasantha Kumar, MD, DM – Christian Medical College, Vellore, Tamil Nadu, India
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1369: Persistence, Effectiveness and Treatment Patterns of Upadacitinib in over 2600 Australian Rheumatoid Arthritis Patients: A Retrospective Analysis from the OPAL Dataset
Abstract Poster Presenter: Geoffrey Littlejohn, MD, MBBS, FRACP, MPH – Geoffrey Littlejohn P/L
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1370: Upadacitinib vs TNFi and Other JAKi Treatment Outcomes in Australian Rheumatoid Arthritis Patients: Descriptive Comparison of Persistence and Effectiveness Using the OPAL Dataset
Abstract Poster Presenter: Geoffrey Littlejohn, MD, MBBS, FRACP, MPH – Geoffrey Littlejohn P/L
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1371: DMARD Utilization Pattern in Older Adults with Rheumatoid Arthritis
Abstract Poster Presenter: Daniela Seelmann, MD – Hospital Clinico Universidad de Chile
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1372: Upadacitinib and Other JAK Inhibitors in the Treatment of Rheumatoid Arthritis - Interstitial Lung Disease. National Multicenter Study Clinical Practice.
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1373: The Effect of Methotrexate on Lipid and Apolipoprotein Levels in RA Goes Hand-in-hand with EULAR Response
Abstract Poster Presenter: Varun Dhir, MD, MBBS, DM – PGIMER, CHD, INDIA
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1374: Exploring Two Decades of Therapeutic Challenges: A Monocentric Experience in Rheumatoid Arthritis Patients Battling Cancer
Abstract Poster Presenter: Roba Ghossan, MSc, MD – Université Paris Saclay Paris
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1375: Effects of Training with Blood Flow Restriction on Muscle Strength in Women with Rheumatoid Arthritis: A Randomized Clinical Trial
Abstract Poster Presenter: Ricardo Xavier, MD, PhD – Universidade Federal do Rio Grande do Sul
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1376: Comparison of the Efficacy of DMARDs in Phase 3 Trials of Different Populations Used in FDA Approvals for Rheumatoid Arthritis Since 2010
Abstract Poster Presenter: Ajay Aggarwal, MD – Aclaris Therapeutics, Inc.
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1377: Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases
Abstract Poster Presenter: Adrián Quevedo-Rodríguez, DM – Servicio Canario de Salud
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1378: Tocilizumab Effect on the Three Pathways of the Complement System in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Marta Hernández-Díaz, MD – Hospital Universitario de Canarias
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1379: Association Between Body Mass Index and the Persistence of Non-TNF-Targeted Biologics in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Dong-Jin Park, MD, PhD – Chonnam National University Medical School and Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1380: Rapid, Clinically Meaningful Pain Improvements Are Associated with Improvements in Other Patient-Reported Outcomes in RA Patients Treated with Upadacitinib
Abstract Poster Presenter: Manish Jain, MD – Ravenswood Rheumatology
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1381: Elimination of CD45RChigh T and B Cells by anti-CD45RC mAb Lead to Efficient Control of Experimental Rheumatoid Arthritis
Abstract Poster Presenter: Carole Guillonneau, PhD (she/her/hers) – AbolerIS Pharma
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1382: Synovial Expression Levels of PD-1, the Target of Rosnilimab, Correlate with Disease Activity and Persist Across Disease Stages and Lines of Therapy in Rheumatoid Arthritis
Abstract Poster Presenter: Costantino Pitzalis, MD;PhD;FRCP (he/him/his) – QMUL
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1383: Proteomics and Machine Learning Accurately Predict Clinical Response to Etanercept Therapy in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Huaqun Zhu, n/a (she/her/hers) – Peking University People's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1384: Disease-modifying Antirheumatic Drugs and Risk of Incident Interstitial Lung Disease Among Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Abstract Poster Presenter: Qianru Zhang, MMSc – Harvard Medical School
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1385: A Novel Oral 3D-Printed Delayed- and Extended-Release Tofacitinib (T19) for the Treatment of Rheumatoid Arthritis and Related Inflammatory Diseases
Abstract Poster Presenter: Yulian Zhang, n/a – Triastek, Inc.
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1386: Olokizumab in Real Clinical Practice: Efficacy and Safety
Abstract Poster Presenter: Sofia Kuzkina, MD (she/her/hers) – R-Pharm
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1387: Olokizumab Effect on Chronic Pain in Rheumatoid Arthritis: Results of the Observational Study
Abstract Poster Presenter: Sofia Kuzkina, MD (she/her/hers) – R-Pharm
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1388: CXC Chemokine Ligand 13 and Rheumatoid Factor as Pharmacodynamic Biomarkers for Abatacept Treatment in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Ting Wang, MD;PhD – University of Washington
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1389: Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter
Abstract Poster Presenter: Alfons den Broeder, MD, PhD – Sint Maartenskliniek
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1390: One-year Real World Evidence Outcomes from the Cohort RADIUS (Real-world Analysis of Upadacitinib in Rheumatoid Arthritis Patients for Improved Understanding and Safety)
Abstract Poster Presenter: José Miguel Sequí-Sabater, Jr, MD,MSc (he/him/his) – La Ribera University Hospital, Rheumatology Department
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1391: Possible Mechanistic Pathways of the Effective “Plants for Joints” Lifestyle and Dietary Intervention for Rheumatoid Arthritis
Abstract Poster Presenter: Carlijn Wagenaar, MD – Reade Rheumatology Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1392: Safety and Efficacy of Upadacitinib (UPA) in Japanese Patients with Rheumatoid Arthritis (RA) and Inadequate Response to Conventional Synthetic DMARDs: Results Through 5 Years from the SELECT-SUNRISE Study
Abstract Poster Presenter: Hideto Kameda, MD, PhD – Toho University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1393: Relationship Between Disease Activity and Adverse Events in Rheumatoid Arthritis: An Integrated Post Hoc Analysis of Upadacitinib Phase 3 Trials
Abstract Poster Presenter: Roy Fleischmann, MD – Metroplex Clinical Research Center and University of Texas Southwestern Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1394: Nationwide Retrospective Cohort Study on Clinical Outcomes in Rheumatoid Arthritis Patients Treated with JAK Inhibitors
Abstract Poster Presenter: Yurilu Gonzalez Moret, MD – Jefferson Einstein Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1395: Effects of Butyrate Supplementation in Modulation of Gut Microbiome and Its Metabolites in New Onset Rheumatoid Arthritis
Abstract Poster Presenter: Rebecca Blank, MD, PhD – NYU
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1396: Low CD47 Expression on B Cells, Induces High B Cell Phagocytosis by Macrophages and Is a Predictive Biomarker of Anti-rituximab Antibodies and Lower Response in Rheumatoid Arthritis
Abstract Poster Presenter: Samuel Bitoun, MD,PhD – CHU Bicêtre APHP
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1397: Temporal Trends in Early Rheumatoid Arthritis (ERA) Patients with Moderate to Severe Disease Activity: A Multicenter Cohort Study of Treatment Strategies and Outcomes in Chinese Patients in the Modern Era
Abstract Poster Presenter: Yafang Deng, MD – Peking Union Medical College Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1398: Difficult to Treat Rheumatoid Arthritis Incidence and Risk Factors in the Early Arthritis UCLouvain Brussels Cohort
Abstract Poster Presenter: Francesco Natalucci, n/a – Sapienza University of Roma, Rheumatology, Department of Clinical, Internistic, Anesthesiological and cardiovascular sciences
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1399: A First-in-Human Clinical Trial Evaluating the Safety and Pharmacokinetics of SOL-116, a Novel Humanized Monoclonal Antibody Targeting Bile Salt-Stimulated Lipase for the Treatment of RA
Abstract Poster Presenter: Karin Franck-Larsson, MD, PhD (she/her/hers) – Lipum AB
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1400: Disease Modifying Anti-rheumatic Drug Use and Association with Survival in Patients with Rheumatoid Arthritis and Newly Diagnosed Lung Cancer
Abstract Poster Presenter: Namrata Singh, MD,MSc – University of Washington
Rheumatoid arthritis (RA)
Sunday, Nov 17th
10:30 AM – 12:30 PM Eastern Time
1401: Risk of Malignancy with TNF-α Inhibitors in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Omair Khan, MD – University of Nebraska Medical Center (UNMC)
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:00 PM – 2:30 PM Eastern Time
17S54: Abstracts: RA – Etiology and Pathogenesis I
Location: Room 146C
Abstract Moderator: John Isaacs, PhD;MBBS – Translational and Clinical Research Institute, NIHR Newcastle Biomedical Research Centre, Newcastle University and The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Abstract Moderator: Alisa Mueller, MD, PhD – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
CME 0 hours
Sunday, Nov 17th
1:00 PM – 2:30 PM Eastern Time
17S55: Abstracts: RA – Treatments: New Approaches
Location: Ballroom B
Abstract Moderator: Sam Dalvi, MD – UAMS
Abstract Moderator: Andreas Kerschbaumer, MD,PhD – Medical University of Vienna
Rheumatoid arthritis (RA)
CME 0 hours
Sunday, Nov 17th
1:00 PM – 1:15 PM Eastern Time
1659: Shared Lung and Joint T Cell Repertoire in Early Rheumatoid Arthritis Driven by Cigarette Smoking
Location: Room 146C
Presenting Author: Koen Venken, PhD – Ghent University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:00 PM – 1:15 PM Eastern Time
1677: Safety and Efficacy of FNS007, a Non-T Cell Receptor Contacting Peptide, for Patients with Active Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial
Location: Ballroom B
Presenting Author: Xing Sun, n/a – Department of Rheumatology and Immunology, Peking University People’s Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:15 PM – 1:30 PM Eastern Time
1660: Systemic Inflammation and Transcriptional Reprogramming Contribute to Progression to Active Rheumatoid Arthritis in ACPA+ Individuals
Location: Room 146C
Presenting Author: Mark Gillespie, PhD – Allen Institute for Immunology
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:15 PM – 1:30 PM Eastern Time
1678: Efficacy, Safety, Pharmacokinetics of Anti-CD40 Antibody Abiprubart in Patients with Rheumatoid Arthritis: A Phase 2, Randomized, Placebo-Controlled 12-week-treatment Proof-of-Concept Study
Location: Ballroom B
Presenting Author: Eric Jenkins, MD – Kiniksa Pharmaceuticals
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:30 PM – 1:45 PM Eastern Time
1661: Rheumatoid Arthritis Synovial Fibroblast Modulation of T Cell Activation
Location: Room 146C
Presenting Author: Melanie Smith, MD;PhD – Hospital for Special Surgery
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:30 PM – 1:45 PM Eastern Time
1679: Differential Pharmacodynamic Changes of Circulated Immune Subsets After Treatment with Abatacept or Adalimumab in Patients with ACPA+ Early RA in the AMPLIFIED Study
Location: Ballroom B
Presenting Author: Jinqi (Jane) LIU, PhD – Bristol Myers Squibb
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:45 PM – 2:00 PM Eastern Time
1662: Using Circulating Soluble Serum Mediator Profiles to Understand the Mechanisms Driving Disease Flare and Drug-free Remission in Rheumatoid Arthritis
Location: Room 146C
Presenting Author: Amy Anderson, PhD, BSc – Newcastle University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
1:45 PM – 2:00 PM Eastern Time
1680: Reporting Quality of Non-inferiority and Equivalence Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review
Location: Ballroom B
Presenting Author: Osama Alalwan, MD – Salmaniya Medical Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
2:00 PM – 2:15 PM Eastern Time
1663: Notch—mediated Fibrogenic Activation Is a Spatial Determinant of RA Treatment Response
Location: Room 146C
Presenting Author: Kartik Bhamidipati, PhD – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
2:00 PM – 2:15 PM Eastern Time
1681: Safe Switching from Originator Tocilizumab to MSB11456 Tocilizumab Biosimilar in Subjects with Moderate-to-Severe Rheumatoid Arthritis: Efficacy, Safety and Immunogenicity Data Following Treatment Transition in a Pivotal, Randomized, Double-blind, Phase III Study
Location: Ballroom B
Presenting Author: Andras Illes, MD, PhD (he/him/his) – Fresenius Kabi SwissBioSim
Rheumatoid arthritis (RA)
Sunday, Nov 17th
2:15 PM – 2:30 PM Eastern Time
1664: Identification of Spatial Determinants of Treatment Response in Rheumatoid Arthritis Synovia
Location: Room 146C
Presenting Author: Roopa Madhu, PhD – Brigham and Women's Hospital
Rheumatoid arthritis (RA)
Sunday, Nov 17th
2:15 PM – 2:30 PM Eastern Time
1682: Early Development of Ocadusertib, a Selective Receptor-Interacting Serine/Threonine-Protein Kinase 1 Inhibitor
Location: Ballroom B
Presenting Author: Eric Hanson, MD – Eli Lilly and Company
Rheumatoid arthritis (RA)
Sunday, Nov 17th
3:00 PM – 4:30 PM Eastern Time
17S65: Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Best Day (RA Subpopulations)
Location: Room 207AB
Abstract Moderator: Jeffrey R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
Abstract Moderator: Jiha Lee, MD;MHS – University of Michigan
Rheumatoid arthritis (RA)
CME 0 hours
Sunday, Nov 17th
3:00 PM – 3:15 PM Eastern Time
1743: What Are the Benefits of Treating Rheumatoid Arthritis Patients to Remission After Achieving Low Disease Activity in Clinical Practice?
Location: Room 207AB
Presenting Author: Michael Weinblatt, MD – Brigham and Women's Hospital/ Harvard Medical School
Rheumatoid arthritis (RA)
Sunday, Nov 17th
3:15 PM – 3:30 PM Eastern Time
1744: Artificial Intelligence: A Novel Tool in the Belt for Improving Rheumatoid Arthritis Outcomes in the National Health Service, United Kingdom
Location: Room 207AB
Presenting Author: Katharine Kalap – Princeton University
Rheumatoid arthritis (RA)
Sunday, Nov 17th
3:30 PM – 3:45 PM Eastern Time
1745: Use of Statins and Its Association with Major Adverse Cardiovascular Outcomes with Tofacitinib versus TNF Inhibitors in a Risk-Enriched Population of Patients with Rheumatoid Arthritis
Location: Room 207AB
Presenting Author: Jon Giles, MD, MPH – Cedars Sinai Medical Center
Rheumatoid arthritis (RA)
Sunday, Nov 17th
3:45 PM – 4:00 PM Eastern Time
1746: Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Rheumatoid Arthritis
Location: Room 207AB
Presenting Author: Andreas Kerschbaumer, MD,PhD – Medical University of Vienna
Rheumatoid arthritis (RA)
Sunday, Nov 17th
4:00 PM – 4:15 PM Eastern Time
1747: Native Americans Experience Profound Premature Mortality from Rheumatoid Arthritis
Location: Room 207AB
Presenting Author: Parmita Das, -None- – University of California Los Angeles
Rheumatoid arthritis (RA)
Sunday, Nov 17th
4:15 PM – 4:30 PM Eastern Time
1748: Fracture Incidence Rates in Persons with Rheumatoid Arthritis by Disease Activity Level
Location: Room 207AB
Presenting Author: Rachel Elam, MD, MS (she/her/hers) – Augusta University
Rheumatoid arthritis (RA)
Monday, Nov 18th
9:00 AM – 10:30 AM Eastern Time
18M12: Risk Stratification for Future Rheumatoid Arthritis
Location: Room 207AB
Moderator: Jaime Guzman, MD, MSc – University of British Columbia and BC Children's Hospital
Moderator: Kulveer Mankia, MD – University of Leeds
Rheumatoid arthritis (RA)
CME 1.5 hours
Monday, Nov 18th
9:00 AM – 9:30 AM Eastern Time
Risk Stratification for Future Rheumatoid Arthritis Using Arthralgia-Based Approaches
Location: Room 207AB
Speaker: Annette van der Helm-van Mil, professor – LUMC
Rheumatoid arthritis (RA)
Monday, Nov 18th
9:30 AM – 10:00 AM Eastern Time
Risk Stratification for Future Rheumatoid Arthritis Using Population-Based Approaches
Location: Room 207AB
Speaker: Kevin Deane, MD,PhD – University of Colorado Denver Anschutz Medical Campus
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:00 AM – 10:30 AM Eastern Time
Application of Risk Stratification in Prevention Trials in Rheumatoid Arthritis
Location: Room 207AB
Speaker: Andrew Cope, MD;PhD – King's College London
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
RA – Treatment Poster III
Rheumatoid arthritis (RA)
CME 0 hours
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
RA – Diagnosis, Manifestations, & Outcomes Poster III
Rheumatoid arthritis (RA)
CME 0 hours
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2208: Clinical, Imaging and Treatment Characteristics of Patients with Progressive Systemic Autoimmune Rheumatic Disease-related Interstitial Lung Diseases (SARD-ILDs) in the ILD-PRO Registry
Abstract Poster Presenter: Ann Chauffe, DO, MPH – Boehringer Ingelheim
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2209: Impact of Common Infections on Medication Interruptions, Quality of Life, and Disease Flares in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Michael George, MD, MSc – University of Pennsylvania
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2210: Comparison of Dual RF and Anti-CCP Seropositive, Single Seropositive, and Seronegative RA on Radiographic Changes, Flares, and Mortality
Abstract Poster Presenter: Rebecca Brooks, MD (she/her/hers) – Mayo Clinic
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2211: Identifying Clinical Predictors of Difficult-to-Treat Rheumatoid Arthritis Using Machine Learning-based Techniques
Abstract Poster Presenter: Jiri Baloun, PhD – Institute of Rheumatology
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2212: Seropositive Arthralgias: A Comprehensive Analysis of the Reuma-Check Cohort
Abstract Poster Presenter: Rodrigo Garcia Salinas, MD – Hospital Italiano La Plata
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2213: Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis
Abstract Poster Presenter: Vanshika Sabharwal, PhD (she/her/hers) – MMDU, Mullana, Ambala India and Healing Touch city clinic, Chandigarh, India
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2214: Confirming a Value for Rheumatoid Arthritis Flares Based on Changes in CDAI, SDAI and RAPID3
Abstract Poster Presenter: Irtza Badar, MD – Mercy Catholic Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2215: Treat (Depression to Reach)-to-Target in Rheumatoid Arthritis
Abstract Poster Presenter: Sibel Aydin, MD – University of Ottawa - Ottawa
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2216: Additive Impact of Rheumatoid Arthritis and HBcAb+ on All-cause and Cardiovascular Mortality
Abstract Poster Presenter: Leiyi Yang, MD – Sichuan University
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2217: A Significant Alteration in Circulating Endocannabinoid Levels in Rheumatoid Arthritis and Fibromyalgia Syndrome Patients and Its Correlation with Diseases Severity
Abstract Poster Presenter: Howard Amital, MD – Sheba Medical Center, Tel-Hashomer, Israel
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2218: Association Between Frailty and Peri-Operative Inpatient Adverse Outcomes Among Patients with and Without Rheumatoid Arthritis
Abstract Poster Presenter: Ali Yazdanyar, DO, PhD, MS – Perelman School of Medicine at the University of Pennsylvania
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2219: Association of Chondrocalcinosis with Disease Activity and Drug Response in Rheumatoid Arthritis: Baseline Characteristics of the Swiss Rheumatoid Arthritis Outcomes Cohort
Abstract Poster Presenter: Tobias Maningold, MD – Department of Rheumatology, Inselspital University Hospital Bern, Bern, Switzerland.
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2220: Outcomes in Seronegative Rheumatoid Arthritis and Undifferentiated Arthritis
Abstract Poster Presenter: Andrew Price, DO – Walter Reed National Military Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2221: Association Between Serum Uric Acid/Serum Creatinine Index and Carotid Plaque in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Maria Elizondo-Benitez, MD (she/her/hers) – Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2222: Primary Lung Involvement in Early Rheumatoid Arthritis
Abstract Poster Presenter: Martí Aguilar Coll, MD – Bellvitge University Hospital
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2223: Validation Study in Early Rheumatoid Arthritis Patients of the Spanish Society of Rheumatology (SER)/Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Screening Criteria for Interstitial Lung Disease
Abstract Poster Presenter: Martí Aguilar Coll, MD – Bellvitge University Hospital
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2224: Age of Onset of Rheumatoid Arthritis and Radiographic Changes
Abstract Poster Presenter: Masaru Shimizu, MD, PhD, MPH (he/him/his) – University of Tsukuba
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2225: Role of Fatigue in Difficult to Treat Rheumatoid Arthritis
Abstract Poster Presenter: Maria Rodriguez-Laguna, MD – Resident in Rheumatology
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2226: Site-specific Differences in the Association of Non-vertebral Major Osteoporotic Fractures and Rheumatoid Arthritis
Abstract Poster Presenter: John Chen, MD – Kaiser Permanente Oakland Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2227: Worrisome Mortality Trends over 20 Years Among Patients with Underlying Ischemic Heart Disease and Rheumatoid Arthritis
Abstract Poster Presenter: Yukthi Mudiam, MBBS – Apollo Institute of Medical Sciences and Research, Hyderabad
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2228: Feasibility, Safety, and Application for Clinical Indication and Research Purposes of Synovial Tissue Analysis in Rheumatoid Arthritis
Abstract Poster Presenter: Cécile Van Mullem – Cliniques Universitaires Saint-Luc � Universit� catholique de Louvain (UCLouvain) � Institut de Recherche Exp�rimentale et Clinique (IREC), Rheumatology
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2229: Aptamer Based Proteomic Profiling Demonstrates Significant Differences in Methotrexate Responders versus Non-responders in Newly Diagnosed Rheumatoid Arthritis and Adds Potential Value to Clinical Examination
Abstract Poster Presenter: Kaien Gu, MD, FRCPC – Feinstein Institutes for Medical Research
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2230: Relationship Between the Complement System and Serum Lipid Profile in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Maria Garcia Gonzalez, MD – Hospital Universitario de Canarias
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2231: Treatment Response over the First 6 Months in Newly Diagosed RA Patients by Pain, Anxiety, Depression & Fatigue (PADF) Symptom Clusters: Results from the Canadian Early Arthritis Cohort
Abstract Poster Presenter: Susan Bartlett, PhD (she/her/hers) – Centre for Outcomes Research & Eval
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2232: Anti-RA33 Autoantibodies Are Unique, Sensitive Biomarkers for the Identification of Seronegative Rheumatoid Arthritis in a U.S. Cohort
Abstract Poster Presenter: Andrew Concoff, MD – Exagen, Inc.
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2233: Maximizing Diagnostic Sensitivity: Combined Anti-RA33, Anti-CarP, and Anti-PAD4 Autoantibodies in Seronegative Rheumatoid Arthritis
Abstract Poster Presenter: Andrew Concoff, MD – Exagen, Inc.
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2234: Pulmonary Damage Biomarkers and Progression of Rheumatoid Arthritis-associated Interstitial Lung Disease in a Prospective Longitudinal Cohort
Abstract Poster Presenter: Sung Hae Chang, MD, PhD, MPH – Brigham and Women's Hospital /Harvard Medical School /Soonchunhyang University College of Medicine
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2235: The Updated PREVENT (Predicting Risk of CVD EVENTs) Algorithm Is Not Able to Indicate Subclinical Coronary or Carotid Atherosclerosis Better Than the Traditional Pooled Cohort Equations in Rheumatoid Arthritis
Abstract Poster Presenter: J. Alex B. Gibbons, BA – Columbia University Vagelos College of Physicians & Surgeons
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2236: Relation Between Sociodemographic Factors and Hand Function in Patients with Early Rheumatoid Arthritis
Abstract Poster Presenter: Carl Turesson, MD, PhD – Lund University
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2237: The Association Between Bariatric Surgery and Incident Rheumatoid Arthritis
Abstract Poster Presenter: Helana Jeries, MD – Galilee Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2238: The Effect of Inflammation on Cardiovascular Risk in Rheumatoid Arthritis Varies According to Sex and Anticitrullinated Protein Antibody Status
Abstract Poster Presenter: George Karpouzas, MD – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2239: Age, Seropositivity and Inflammation Determine Risk versus Benefit of Endogenous Estrogens on Coronary Atherosclerosis in Rheumatoid Arthritis
Abstract Poster Presenter: George Karpouzas, MD – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2240: Methotrexate Use Influenced the Effect of Inflammation on Cardiovascular Risk Differently in Anticitrullinated Protein Antibody Negative and Positive Patients with Rheumatoid Arthritis
Abstract Poster Presenter: George Karpouzas, MD – Harbor-UCLA Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2241: Associations Between Disease Activity, Physical Function and Anti-rheumatic Medications with All-cause Mortality in Rheumatoid Arthritis (RA): Data from a Canadian RA Registry
Abstract Poster Presenter: Mohammad Movahedi, MD, PhD (he/him/his) – Toronto General Hospital Research Institute, University Health Network
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2242: A Cross-sectional Study on Predictors of COVID-19 Infection, Admission and Mortality and Effect of Immunomodulating Treatments in Rheumatoid Arthritis
Abstract Poster Presenter: Sibel Aydin, MD – University of Ottawa - Ottawa
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2243: A Cross-sectional Study of the Association Between Anxiety State and Various Factors in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Yusuke Miwa, MD, PhD – Division of Rheumatology, Department of Medicine, School of Medicine, Showa University
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2244: Unveiling Synovial Protein Contributions to Serum Inflammation, Disease Activity, and Treatment Outcomes in RA Patients
Abstract Poster Presenter: Chary Lopez-Pedrera, PhD (she/her/hers) – IMIBIC - Reina Sofia Hospital
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2245: Clinical Efficacy and Molecular Cardiovascular Changes of Baricitinib in Biologic-naïve Patients with Rheumatoid Arthritis. Direct Comparative Analysis with TNF Inhibitors and Conventional DMARDs
Abstract Poster Presenter: Chary Lopez-Pedrera, PhD (she/her/hers) – IMIBIC - Reina Sofia Hospital
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2246: Safety and Efficacy of Cannabidiol in Rheumatoid Arthritis Patients: A Phase 1B Pilot Randomized Placebo Controlled Trial
Abstract Poster Presenter: Veena Ranganath, MD,MS – UCLA
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2247: Pro-inflammatory Monocytes and CD11c Expression in ACPA Positive Individuals with Arthralgia and Their Associations with Subclinical Synovitis Preceding the Onset of Arthritis
Abstract Poster Presenter: Klara Prajzlerova, PhD – Institute of Rheumatology
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2248: Association of Integrative Health Practices with Health-Related Quality of Life in Women with Rheumatoid Arthritis
Abstract Poster Presenter: Sarah Lieber, MD, MS (she/her/hers) – Hospital for Special Surgery
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2249: Assessment of Interstitial Lung Disease in Rheumatoid Arthritis Patients Treated with JAK Inhibitors: A National Multicenter Observational Study from the MAJIK-SFR Registry
Abstract Poster Presenter: Jérôme Avouac, MD,PhD – Université de Paris Cité
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2250: Cause Specific Mortality Differs in Rheumatoid Arthritis by Sex and Seropositivity
Abstract Poster Presenter: Elena Joerns, MD, MPH – Mayo Clinic
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2251: Stress-Related Neural Activity Measured with FDG-PET/CT Is Associated with Articular Disease Activity, Systemic Inflammation, and Treatment-associated Change in Arterial Inflammation in Rheumatoid Arthritis
Abstract Poster Presenter: Jon Giles, MD, MPH – Cedars Sinai Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2252: Long-term Efficacy of Filgotinib Monotherapy and Combination Therapy: Interim Results from a Post Hoc Analysis of the FINCH 4 Study
Abstract Poster Presenter: Tom Huizinga, MD, PhD – Leiden University Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2253: A Phase 1 Single Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of ZB002, an Anti-TNFα mAb Designed for Extended Half-life, in Healthy Volunteers
Abstract Poster Presenter: Rachel Kirk, MS – Zenas BioPharma
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2254: A Phase 1 Single Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of ZB004, a CTLA-4-Ig Fusion Protein Designed for Increased Binding Affinity and Extended Half-life, in Healthy Volunteers
Abstract Poster Presenter: Shan Yu, PhD – Zenas BioPharma
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2255: Differences in Pharmacological Prescription to Patients with Recent-onset Arthritis: Analysis from the Gender Perspective
Abstract Poster Presenter: Maryia Nikitsina, MD (she/her/hers) – University hospital la Princesa, Madrid
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2256: Depletion of Citrullinated Vimentin-reactive Follicular Helper T Cells with Treatment-induced Remission of Recent-onset Rheumatoid Arthritis When Compared to Non-remission at 6 Months
Abstract Poster Presenter: Jia Yi Hee, BSc, MSc – The University of Queensland
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2257: Comparison of the Safety and Effectiveness of Originator Rituximab (Mabthera®) versus Biosimilar (Riximyo®) in Rheumatoid Arthritis: A Retrospective Unicentric Analysis
Abstract Poster Presenter: Bárbara Bayeh, MD – University of São Paulo
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2258: The Window of Opportunity: A Concept Also Applicable to Undifferentiated Arthritis
Abstract Poster Presenter: Maria Paula Alvarez, MD (she/her/hers) – Hospital Universitario de La Princesa
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2259: Effects of Anti-Obesity Medications in RA Patients
Abstract Poster Presenter: Elizabeth Dente, MD – UCLA Health
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2260: Statin Use in Patients with Rheumatoid Arthritis (RA) and Osteoarthritis: Are RA Patients More Likely to Receive Statins?
Abstract Poster Presenter: Axi Patel, MD, MPH – University of Illinois at Chicago; Jesse Brown VA Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2261: Risk of Cervical Intraepithelial Neoplasia During Janus Kinase (JAK) Inhibitor Treatment in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
Abstract Poster Presenter: Mi-Ra Cho, MD – Asan medical center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2262: Window of Opportunity in the Treatment of Rheumatoid Arthritis - Interstitial Lung Disease with Abatacept. National Multicenter Study of 526 Patients
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2263: The Potential Use of Circulating Extracellular Vesicles for Improved Diagnosis and Therapy in Rheumatic Inflammatory/autoimmune Diseases: Proof of Concept Studies
Abstract Poster Presenter: Gilad Halpert, PhD – CAHIM SHEBA MEDICAL CENTER
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2264: The Risk of Malignancy and Major Adverse Cardiovascular Events with the Use of Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Real-World Evidence
Abstract Poster Presenter: Majeed Haider, MD – Salmaniya Medical Hospital
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2265: Patient’s Global Assessment of Disease Activity Is the Most Relevant Factor for Near-Miss of Boolean 2.0 Remission in Patients with Rheumatoid Arthritis: Post Hoc Analysis from the Observational UPwArds Study
Abstract Poster Presenter: Torsten Witte, MD – Dept of Rheumatology and Immunology
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2266: Immunosuppressive Medications and Common Infections in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Michael George, MD, MSc – University of Pennsylvania
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2267: A Novel Blood-based Assay That Predicts Clinical Response to TNFα Inhibitors or Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Maggie Louie, PhD, MS – Aqtual, Inc.
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2268: The Discontinuation and Effectiveness of Sequential Advanced Therapy in Rheumatoid Arthritis, a Real-World Data
Abstract Poster Presenter: Sibel Aydin, MD – University of Ottawa - Ottawa
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2269: Adalimumab Dose Reduction Using Therapeutic Drug Monitoring to Manage Low Disease Activity in Rheumatoid Arthritis: A Single-Blind, Non-Inferiority, Randomized Clinical Trial
Abstract Poster Presenter: Sadaf Atiqi, PhD (she/her/hers) – Reade
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2270: Low Yield of Routine Serological Screening for Hepatitis B in Patients with Rheumatoid Arthritis Starting Rituximab Therapy in a Non-Endemic Country
Abstract Poster Presenter: Pauline Bovens, MSc (she/her/hers) – Sint Maartenskliniek
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2271: Intra-Articular Injection of Human Bone Marrow-Derived Mesenchymal Stem Cells in Knee Osteoarthritis: A Randomized, Double-Blind, Controlled Trial
Abstract Poster Presenter: Jennifer Lee, MD, PhD – Seoul st mary's hospital
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2272: Evolution of Methotrexate and Prednisone Use in the Era of Biologic Therapy: 15-Year Findings from a Large Rheumatoid Arthritis Registry
Abstract Poster Presenter: Dimitrios Pappas, MD,MPH – CorEvitas
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2273: Time-Trends in Real-World Glucocorticoid Treatment Strategies in Patients with Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort(CATCH) Study
Abstract Poster Presenter: Susan Bartlett, PhD (she/her/hers) – Centre for Outcomes Research & Eval
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2274: Efficacy and Safety of the Biased Melanocortin Receptor Agonist AP1189/resomelagon in Combination with Methotrexate in DMARD-naïve Rheumatoid Arthritis Patients: The EXPAND Trial
Abstract Poster Presenter: Asger Bihlet, PhD, MSc – NBCD A/S
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2275: Cardiovascular and Cancer Safety of JAKi Compared to TNFi in Patients with Rheumatoid Arthritis: Results from a National Registry of Advanced Therapies
Abstract Poster Presenter: Lucia Otero-Varela, MSc – Spanish Society of Rheumatology
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2276: Use of Methotrexate and TNF-α Inhibitors in Patients with Rheumatoid Arthritis-associated Interstitial Lung Disease: A Survey of Rheumatologists
Abstract Poster Presenter: Elizabeth Park, MD, MSc – Columbia University Medical Center
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2277: Switching to a Targeted Drug with a Different Mode of Action After Discontinuation of the First TNF Inhibitor Is Associated with Better Drug Survival Compared to a Second TNF Inhibitor in Rheumatoid Arthritis: A Propensity Score-matched Analysis from the Czech ATTRA Registry
Abstract Poster Presenter: Heřman Mann, MD, PhD (he/him/his) – Revmatologický ústav
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2278: Similar Etanercept Adherence in Individuals with Rheumatic Disease Initiating Originator and Biosimilar: A Population-Based Study
Abstract Poster Presenter: Olga Tsyruk, BSc – McGill University
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2279: Discontinuation Pattern of Glucocorticoids in Patients with Rheumatoid Arthritis Initiating Biologics or Targeted Synthetic DMARDs in Routine Care
Abstract Poster Presenter: Isabel Castrejon, MD,PhD – Hospital General Universitario Gregorio Marañon
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2280: Development of a Blood-based Cell-free DNA Classifier Assay to Predict Biologic and Targeted Synthetic DMARDs Response in Rheumatoid Arthritis Patients (PRIMA-102)
Abstract Poster Presenter: Signe Fransen, MSc – Aqtual
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2281: Assessment of Comparative Efficacy Between Candidate Biosimilar AVT05 and Reference Golimumab
Abstract Poster Presenter: Monica Luque, MD – Alvotech Swiss AG
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2282: Defining a Personalized Treatment Approach to Rheumatoid Arthritis: Using Genetic Markers of TNFi Response
Abstract Poster Presenter: M. Elaine Husni, MD;MPH – Cleveland Clinic
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2283: Characterization of Second-Line Therapy After First Janus Kinase Inhibitor Use: Results from the CorEvitas RA Registry
Abstract Poster Presenter: Joshua F. Baker, MD, MS – University of Pennsylvania
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2284: Real-World Evidence of the Antifibrotic Nintedanib in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 74 Patients from Clinical Practice
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Hospital Universitario Marqués de Valdecilla, IDIVAL
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2285: Safety and Tolerability of a Combination of Curcumin, Omega-3 and Vitamin-D: Results from the PASCOD Study, an RA Prevention Protocol
Abstract Poster Presenter: Liam O'Neil, MD, MHS – University of Manitoba
Rheumatoid arthritis (RA)
Monday, Nov 18th
10:30 AM – 12:30 PM Eastern Time
2286: Certolizumab Inhibits Radiographic Progression Even in RA Patients with High Rheumatoid Factor Levels: A Pooled, Post-Hoc Analysis of Two Phase 3 Trials
Abstract Poster Presenter: Josef Smolen, MD – Medical University of Vienna
Rheumatoid arthritis (RA)
Monday, Nov 18th
1:00 PM – 2:30 PM Eastern Time
18M57: Abstracts: RA – Animal Models
Location: Room 152A
Abstract Moderator: Salahuddin Ahmed, PhD,MSc – Washington State University
Abstract Moderator: William Ambler, MD – NIH/NIAMS
Rheumatoid arthritis (RA)
CME 0 hours
Monday, Nov 18th
1:00 PM – 1:15 PM Eastern Time
2539: Telocytes Integrated into Mast Cells and Joint-Draining Lymphatic Vessels Potentially Regulate Lymphatic Clearance
Location: Room 152A
Presenting Author: Yue Peng, MS (she/her/hers) – University of Rochester
Rheumatoid arthritis (RA)
Monday, Nov 18th
1:15 PM – 1:30 PM Eastern Time
2540: Characterizing the Functional Role of Type I Interferons in Inflammatory Arthritis
Location: Room 152A
Presenting Author: Mary Huang, BS – Hospital for Special Surgery
Rheumatoid arthritis (RA)
Monday, Nov 18th
1:30 PM – 1:45 PM Eastern Time
2541: Probiotic Modulation of Gut Microbiota Mitigates Early Rheumatoid Arthritis Progression: Insights from Pre-Clinical Models
Location: Room 152A
Presenting Author: Tong Wu, MD (she/her/hers) – West China School of Medicine and West China Hospital, Sichuan University
Rheumatoid arthritis (RA)
Monday, Nov 18th
1:45 PM – 2:00 PM Eastern Time
2542: Group 2 Innate Lymphoid Cells Aggravates Development of Inflammatory Arthritis
Location: Room 152A
Presenting Author: Anders Nguyen, MSc – University of Gothenburg
Rheumatoid arthritis (RA)
Monday, Nov 18th
2:00 PM – 2:15 PM Eastern Time
2543: Novel IgG Degrader BHV-1300 Demonstrates the Ability to Remove Anti-bDMARD ADA and Allows for Co-administration with Fc-containing Biologics
Location: Room 152A
Presenting Author: David Pirman, PhD – Biohaven
Rheumatoid arthritis (RA)
Monday, Nov 18th
2:15 PM – 2:30 PM Eastern Time
2544: Spatial Transcriptomics Suggests Synovial Macrophage Niches Are Sexually Dimorphic in a Mouse Inflammatory Arthritis Model
Location: Room 152A
Presenting Author: Richard Bell, PhD – Hospital for Special Surgery
Rheumatoid arthritis (RA)
Tuesday, Nov 19th
9:30 AM – 10:30 AM Eastern Time
19T07: SOTA: Busy Bs: Deciphering B Cell Contributions to Rheumatoid Synovitis
Location: Room 144ABC
Moderator: Anne Davidson, MBBS;FRACP – Feinstein Institutes for Medical Research
Rheumatoid arthritis (RA)
CME 1 hours
Tuesday, Nov 19th
9:30 AM – 10:30 AM Eastern Time
Busy Bs: Deciphering B Cell Contributions to Rheumatoid Synovitis
Location: Room 144ABC
Speaker: Jennifer Anolik, MD;PhD – University of Rochester Medical Center
Rheumatoid arthritis (RA)
Tuesday, Nov 19th
11:00 AM – 12:30 PM Eastern Time
19T14: Abstracts: RA – Treatments II: Refining Use of Established Therapies
Location: Room 143ABC
Abstract Moderator: Jonathan Kay, MD – UMass Chan Medical School
Abstract Moderator: Jon Giles, MD, MPH – Cedars Sinai Medical Center
Rheumatoid arthritis (RA)
CME 0 hours
Tuesday, Nov 19th
11:00 AM – 11:15 AM Eastern Time
2671: Subcutaneous Abatacept vs Adalimumab Head-to-Head Comparison in Adults with Early, Dual Seropositive Rheumatoid Arthritis, Positive for the Shared Epitope HLA Class II Risk Alleles, and an Inadequate Response to Methotrexate: Results from a Phase 3 Trial
Location: Room 143ABC
Presenting Author: Michael Weinblatt, MD – Brigham and Women's Hospital/ Harvard Medical School
Rheumatoid arthritis (RA)
Tuesday, Nov 19th
11:15 AM – 11:30 AM Eastern Time
2672: Prevention of the Development of Rheumatoid Arthritis by a 1-year Course of Methotrexate in ACPA-negative Arthralgia Patients at Increased Risk for Rheumatoid Arthritis: 4 Year Results of the TREAT EARLIER Trial
Location: Room 143ABC
Presenting Author: Quirine Dumoulin, MD, MSc – Leiden University Medical Centre
Rheumatoid arthritis (RA)
Tuesday, Nov 19th
11:30 AM – 11:45 AM Eastern Time
2673: Changes in Mortality Risk After Stopping Glucocorticosteroids – a Population-based Study in Rheumatoid Arthritis
Location: Room 143ABC
Presenting Author: Diane Lacaille, MD, FRCPC – Arthritis Research Canada, University of British Columbia
Rheumatoid arthritis (RA)
Tuesday, Nov 19th
11:45 AM – 12:00 PM Eastern Time
2674: Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a 1st-Line Tumor Necrosis Factor Inhibitor in the United States
Location: Room 143ABC
Presenting Author: Christina Charles-Schoeman, MD, MS – UCLA Medical Center
Rheumatoid arthritis (RA)
Tuesday, Nov 19th
12:00 PM – 12:15 PM Eastern Time
2675: Which Arthralgia Patients at Risk for RA Benefited from Treatment with Methotrexate?; Results from the TREAT EARLIER Trial
Location: Room 143ABC
Presenting Author: Stijn Claassen, MD (he/him/his) – Leiden University Medical Center
Rheumatoid arthritis (RA)
Tuesday, Nov 19th
12:15 PM – 12:30 PM Eastern Time
2676: Timeframe for Initiating Methotrexate and Vaccine Response Against Pneumococcus in Rheumatoid Arthritis: The VACIMRA Study
Location: Room 143ABC
Presenting Author: Jacques MOREL, MD,PhD (he/him/his) – CHU and University of Montpellier
Rheumatoid arthritis (RA)